AML WITH GENE MUTATIONS

Clinical trials for AML WITH GENE MUTATIONS explained in plain language.

Never miss a new study

Get alerted when new AML WITH GENE MUTATIONS trials appear

Sign up with your email to follow new studies for AML WITH GENE MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for leukemia patients who have run out of options

Disease control Recruiting now

This is a first-in-human study to test a new drug, ZE46-0134, for adults with a hard-to-treat blood cancer called acute myeloid leukemia (AML). The cancer has come back or resisted standard treatment and has specific genetic changes (FLT3 or spliceosome mutations). The main goals…

Matched conditions: AML WITH GENE MUTATIONS

Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

AML WITH GENE MUTATIONS

Get alerted when new AML WITH GENE MUTATIONS trials appear

New hope for leukemia patients who have run out of options